前往化源商城

Ondansetron-13C,d3

更新时间:2024-01-20 18:03:51

Ondansetron-13C,d3结构式
Ondansetron-13C,d3结构式
委托求购
常用名 Ondansetron-13C,d3 英文名 Ondansetron-13C,d3
CAS号 2699607-85-5 分子量 297.37
密度 N/A 沸点 N/A
分子式 C1713CH16D3N3O 熔点 N/A
MSDS N/A 闪点 N/A

 Ondansetron-13C,d3用途


昂丹司琼-13C,d3是13C和氘标记的。

 Ondansetron-13C,d3名称

英文名 Ondansetron-13C,d3

 Ondansetron-13C,d3生物活性

描述 昂丹司琼-13C,d3是13C和氘标记的。
相关类别
体外研究 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而备受关注[27]。
参考文献

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

[2]. Brown AM, et al. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol. 1998 Mar 15;507 ( Pt 3):653-65.

[3]. Barann M, et al. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):255-65.

[4]. Wildeboer KM, et al. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Res. 2009 Dec 1;1300:41-50.

[5]. Khedhaier A, et al. Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. Chronobiol Int. 2003 Nov;20(6):1103-16.

[6]. Umathe SN, et al. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behav Pharmacol. 2009 Feb;20(1):78-83.

[7]. Doggrell SA, et al. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opin Drug Saf. 2013 May;12(3):421-31.

 Ondansetron-13C,d3物理化学性质

分子式 C1713CH16D3N3O
分子量 297.37